AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
A health perception score predicts cardiac events in patients with heart failure: Results from the IMPRESS trial
Authors: Havranek, EP Lapuerta, P Simon, TA L'Italien, G Block, AJ Rouleau, JL
Citation: Ep. Havranek et al., A health perception score predicts cardiac events in patients with heart failure: Results from the IMPRESS trial, J CARD FAIL, 7(2), 2001, pp. 153-157
Papillary muscle rupture complicating an acute myocardial infarction
Authors: Dias, B Graba, J Siu, S Rouleau, JL Yau, T Butany, J
Citation: B. Dias et al., Papillary muscle rupture complicating an acute myocardial infarction, CAN J CARD, 17(6), 2001, pp. 722-723
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma
Authors: Cyr, M Lepage, Y Blais, C Gervais, N Cugno, M Rouleau, JL Adam, A
Citation: M. Cyr et al., Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma, AM J P-HEAR, 281(1), 2001, pp. H275-H283
Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction
Authors: Blais, C Lapointe, N Rouleau, JL Clement, R Gervais, N Geadah, D Adam, A
Citation: C. Blais et al., Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction, PEPTIDES, 22(6), 2001, pp. 953-962
Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed
Authors: Dumoulin, MJ Adam, A Rouleau, JL Lamontagne, D
Citation: Mj. Dumoulin et al., Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed, J CARDIO PH, 37(4), 2001, pp. 359-366
Bradykinin metabolism and hypotensive transfusion reactions
Authors: Cyr, M Eastlund, T Blais, C Rouleau, JL Adam, A
Citation: M. Cyr et al., Bradykinin metabolism and hypotensive transfusion reactions, TRANSFUSION, 41(1), 2001, pp. 136-150
Effect of carvedilol on survival in severe chronic heart failure.
Authors: Packer, M Coats, AJS Fowler, MB Katus, HA Krum, H Mohacsi, P Rouleau, JL Tendera, M Castaigne, A Roecker, EB Schultz, MK DeMets, DL
Citation: M. Packer et al., Effect of carvedilol on survival in severe chronic heart failure., N ENG J MED, 344(22), 2001, pp. 1651-1658
Myocardial contractile responsiveness to endothelin-1 in the post-infarction rat model of heart failure: Effects of chronic quinapril
Authors: Qi, XL Sia, YT Stewart, DJ Wei, GC Nguyen, QT Cernacek, P Picard, P Sirois, M Rouleau, JL
Citation: Xl. Qi et al., Myocardial contractile responsiveness to endothelin-1 in the post-infarction rat model of heart failure: Effects of chronic quinapril, J MOL CEL C, 33(11), 2001, pp. 2023-2035
Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit - Importance of kinins and influence on angiotensin II type 1 receptor signaling pathway
Authors: Rouleau, JL Kapuku, G Pelletier, S Gosselin, H Adam, A Gagnon, C Lambert, C Meloche, S
Citation: Jl. Rouleau et al., Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit - Importance of kinins and influence on angiotensin II type 1 receptor signaling pathway, CIRCULATION, 104(8), 2001, pp. 939-944
Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat - Importance of timing
Authors: Nguyen, QT Cernacek, P Sirois, MG Calderone, A Lapointe, N Stewart, DJ Rouleau, JL
Citation: Qt. Nguyen et al., Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat - Importance of timing, CIRCULATION, 104(17), 2001, pp. 2075-2081
Vasopeptidase inhibitors - A new therapeutic concept in cardiovascular disease?
Authors: Corti, R Burnett, JC Rouleau, JL Ruschitzka, F Luscher, TF
Citation: R. Corti et al., Vasopeptidase inhibitors - A new therapeutic concept in cardiovascular disease?, CIRCULATION, 104(15), 2001, pp. 1856-1862
beta-blockers in congestive heart failure - A Bayesian meta-analysis
Authors: Brophy, JM Joseph, L Rouleau, JL
Citation: Jm. Brophy et al., beta-blockers in congestive heart failure - A Bayesian meta-analysis, ANN INT MED, 134(7), 2001, pp. 550-560
Recovery of ventricular function after myocardial infarction in the reperfusion era: The healing and early afterload reducing therapy study
Authors: Solomon, SD Glynn, RJ Greaves, S Ajani, U Rouleau, JL Menapace, F Arnold, JMO Hennekens, C Pfeffer, MA
Citation: Sd. Solomon et al., Recovery of ventricular function after myocardial infarction in the reperfusion era: The healing and early afterload reducing therapy study, ANN INT MED, 134(6), 2001, pp. 451-458
Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction
Authors: White, M Rouleau, JL Hall, C Arnold, M Harel, F Sirois, P Greaves, S Solomon, S Ajani, U Glynn, R Hennekens, C Pfeffer, M
Citation: M. White et al., Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction, AM HEART J, 142(6), 2001, pp. 1056-1064
The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) trial
Authors: Pfeffer, MA Domanski, M Verter, J Dunlap, M Flaker, GC Gersh, B Hsia, J Goldberg, AD Limacher, MC Maggioni, AP Rosenberg, Y Rouleau, JL Warnica, JW Wasserman, AG Braunwald, E
Citation: Ma. Pfeffer et al., The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) trial, AM HEART J, 142(3), 2001, pp. 375-377
Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): An echocardiography-based structural analysis
Authors: Aikawa, Y Rohde, L Plehn, J Greaves, SC Menapace, F Arnold, JM Rouleau, JL Pfeffer, MA Lee, RT Solomon, SD
Citation: Y. Aikawa et al., Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): An echocardiography-based structural analysis, AM HEART J, 141(2), 2001, pp. 234-242
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins
Authors: Blais, C Marceau, F Rouleau, JL Adam, A
Citation: C. Blais et al., The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins, PEPTIDES, 21(12), 2000, pp. 1903-1940
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure
Authors: Suskin, N McKelvie, RS Burns, RJ Latini, R Pericak, D Probstfield, J Rouleau, JL Sigouin, C Solymoss, CB Tsuyuki, R White, M Yusuf, S
Citation: N. Suskin et al., Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure, EUR HEART J, 21(16), 2000, pp. 1368-1375
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial (vol 356, pg 615, 2000)
Authors: Rouleau, JL
Citation: Jl. Rouleau, Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial (vol 356, pg 615, 2000), LANCET, 356(9243), 2000, pp. 1774-1774
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
Authors: Rouleau, JL Pfeffer, MA Stewart, DJ Isaac, D Sestier, F Kerut, EK Porter, CB Proulx, G Qian, CL Block, AJ
Citation: Jl. Rouleau et al., Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial, LANCET, 356(9230), 2000, pp. 615-620
Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts
Authors: Blais, C Fortin, D Rouleau, JL Molinaro, G Adam, A
Citation: C. Blais et al., Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts, J PHARM EXP, 295(2), 2000, pp. 621-626
Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy - The randomized evaluation of strategies for left ventricular dysfunction pilot study
Authors: Cirillo, W Decanini, R Coelho, OR Avezum, A Peixoto, MSP Piegas, LS Neto, JMR Paiva, M Carvalho, AC de Almeida, DR Fernandes, IML Malavasi, MC Pavanello, R Canesin, M Ishii, S Barretto, ACP Imrie, J Moore, R Woo, K Bernstein, V Mizgala, HF Mooney, S Hilbich, D Kuritzky, R Rupka, DW Blackwell, MM Breakwell, L Kornder, JM Pearce, SA Polasek, P Richardson, PM Grant, J Isaac, D Beresford, P Giannoccaro, P Roth, D Greenwood, P Muzyka, T Prosser, A Brass, N Hui, W Kvill, L Goeres, M MacDonald, K Senaratne, M Hill, L Humen, D Teo, KK Habib, N Habib, N Teekasingh, S MacKenzie, J McEwen, B Morris, A Dhair, A Lai, C Kwiatkowski, K Brugos, J Nawaz, S Andrews, J Moe, G Freskiw, K Gilbert, B Morgan, CD Bozek, B Halperin, F Ricci, AJ Singh, N Cappelli, G Boyne, T Fallen, E Panju, A Woodcock, G Kent, E Kitching, AD Sullivan, H Tomson, D McKelvie, RS Tsuyuki, RT Yusuf, S Chan, YK Thomson, D Arnold, JMO Hurwitz, G Miles, R Baker, A Haspect, A Smith, S Bedard, J Lavoie, L Dufort, L Harvey, R Lepage, S Elstein, E Fitchett, D Serpa, A Day, L Racine, N Savard, D Sestier, F Gosselin, G Rouleau, JL White, M Whittom, L Kiwan, G Kouz, SM Laforest, M Ouimet, H Carmichael, P Lenis, J Auger, P Grondin, F Saulnier, D Campeau, J Dupuis, R Lauzon, C Genest, M Robitaille, NM Beaudoin, J Belanger, N Houde, G Talbot, P Cossett, J Koilpillai, C Sheridan, WJ Tobin, M Sussex, B Ascoli, G Fraticelli, A Paciaroni, E Como, CO Belluschi, R Ruffa, F Tettamanti, F Cobelli, F Salvucci, F Arpesella, R Campana, C Gavazzi, A Cirrincione, V Ingrilli, F Sciortino, E Boccanelli, A Cacciatore, G Menichelli, M Bosimini, E Giannuzzi, P Marcassa, C Porcu, M Salis, S Sanna, A Comerio, G Gronda, E Mangiavacchi, M Moccetti, T Pasotti, E Sessa, F Levy, WC Probstfield, J Thompson, J Gramberg, M Grover, J Towery, D Ogunyankin, K Singh, BN Celano, J Graham, S Kohn, RM Pande, P Sass, A Wiener, RS Rydzinski, S Starling, RC Young, J Hays, L Naftilan, A Miller, A Varga, A Wofford, R Barnhill, S Brito, RD Harris, L Haspect, A Cristina, T Jarosz, M Kellen, J Kingry, C Letterer, R La Forge, D Liuni, C MacKenzie, J Magi, A Stevens, K Squires, P Yusuf, S Rouleau, JL Maggioni, A Arnold, JMO Avezum, A Burns, R Floras, J Gavazzi, A Held, P Hjalmarson, A Isaac, D Latini, R Lindgren, E McKelvie, RS Piegas, LS Pericak, D Pogue, J Probstfield, J Smith, S Swedberg, K Teo, KK Tsuyuki, RT Vint-Reed, C Wang, Y White, M Wiecek, EM Young, J Johnstone, D Armstrong, PW Packer, M Wedel, H Teo, KK Gavazzi, A Tsuyuki, RT White, M McKelvie, R Anderson, M Holadyk-Gris, I Kucemba, K MacKay, J McKelvie, RS Micks, M Pericak, D Pogue, J Reeve, S Robinson, L Tsuyuki, RT Tucker, J Wiecek, EM Wang, Y Yusuf, S Cernacek, P Joyal, M Poitras, N Rouleau, JL White, M Sirois, P Bevilacqua, M Latini, R Masson, S Torri, M Hall, C Burns, RJ Heeney, T Tadros, S White, M Yusuf, S McKelvie, RS Pericak, D Young, J Latini, R Pogue, J Burns, RJ Probstfield, J Tsuyuki, RT Maggioni, AP Avezum, A Rouleau, JL
Citation: W. Cirillo et al., Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy - The randomized evaluation of strategies for left ventricular dysfunction pilot study, CIRCULATION, 101(4), 2000, pp. 378-384
LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction
Authors: Nguyen, QT Colombo, F Rouleau, JL Dupuis, J Calderone, A
Citation: Qt. Nguyen et al., LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction, BR J PHARM, 130(7), 2000, pp. 1525-1530
Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design
Authors: Pfeffer, MA McMurray, J Leizorovicz, A Maggioni, AP Rouleau, JL Van de Werf, F Henis, M Neuhart, E Gallo, P Edwards, S Sellers, MA Velazquez, E Califf, R
Citation: Ma. Pfeffer et al., Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design, AM HEART J, 140(5), 2000, pp. 727-734
Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan
Authors: Moe, GW Rouleau, JL Charbonneau, L Proulx, G Arnold, JMO Hall, C de Champlain, J Barr, A Sirois, P Packer, M
Citation: Gw. Moe et al., Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan, AM HEART J, 139(4), 2000, pp. 587-595
Risultati: 1-25 | 26-37